Previous Close | 45.71 |
Open | 45.71 |
Bid | 41.00 |
Ask | 44.90 |
Strike | 97.50 |
Expire Date | 2024-06-21 |
Day's Range | 45.71 - 45.71 |
Contract Range | N/A |
Volume | |
Open Interest | 15 |
BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.
Butterfly Network (BFLY) uses proprietary Ultrasound-on-Chip technology to streamline the bladder scanning process.
Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.